A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI

Sponsor
Peiyi Xie
Study ID
NCT07381322
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This project aims to use multi-temporal, multi-parameter MRI features, blood biomarkers, and clinical indicators to accurately assess pseudoprogression following immunotherapy in rectal cancer.

Key Dates

First listed
Feb 2, 2026
Start date
Feb 1, 2026
Status verified
Apr 2026
Primary completion
Dec 31, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: one group
    one group

Primary Outcome Measure

The area under curve (AUC) of receive operating characteristic (ROC) curves of models in prediction pseudoprogression after rectal cancer immunotherapy [ Time Frame: From date of baseline MRI to date of preoperative MRI ]

Central Contacts

  • Peiyi Xie

Find similar trials

Nationwide
Colorectal cancer trialsOncology trialsGI oncology trials

Related Studies